🇺🇸 FDA
Pipeline program

Bedaquiline

PRACTECAL-PKPD

Phase 3 small_molecule active

Quick answer

Bedaquiline for Multi-drug Resistant Tuberculosis is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Multi-drug Resistant Tuberculosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials